CardieX selected as a finalist in the AHA Health Technology & Innovation Competition

We are so thrilled to have been selected as one of five finalists in The American Heart Association Center for Health Technology & Innovation 6th annual Health Tech Competition. Catherine Liao, our Chief Scientific Officer will be presenting our SphygmoCor technology, during the American Heart Association’s Scientific Sessions before a panel of expert judges in Philadelphia on Nov. 11-12. 

The list of finalists include: 

• Ainthoven, based in Melbourne, Florida;  
• CardieX, based in Naperville, Illinois;  
• Cardiosense, based in Chicago;  
• PyrAmes, based in Cupertino, California; and  
• RCE Technologies, based in Carlsbad, California. 

Read the full article here